Medicine
Rivaroxaban 155 mg oral suspension
Rivaroxaban 155 mg oral suspension is a generic prescription medicine for oral use, with its source record on the US FDA register. It is available on request for export supply from India to licensed hospitals, importers and physicians.
Availability
Export supply from India to licensed buyers
Typical lead time
On request
Counted from payment and complete documents
Shipping
Ambient
Store at room temperature between 20 • C to 25 • C (68 • F to 77 • F)…
Key facts
- Active ingredient (INN)
- Rivaroxaban
- Brand
- Sold under the generic name
- Strength
- 155 mg
- Dosage form
- Oral suspension
- Route
- Oral
- Packs
- 1 bottle
- Manufacturer
- Ascend LaboratoriesIndia
- Origin register
- US FDA, United States
- Storage
- Store at room temperature between 20 • C to 25 • C (68 • F to 77 • F), excursions permitted between 15 • C to 30 • C (59 • F to 86 • F). Do not freeze the granules or reconstituted suspension.
- Cold chain
- Not required on record
- Prescription status
- Prescription only
- Controlled substance
- Not recorded as controlled
- ATC code
- B01AF01 Rivaroxaban
- HS code (indicative)
- 3004.90Indicative only. Your customs broker confirms the final tariff code.
- Marketing category
- marketed
- Marketed since
- 7 July 2025
- Identifiers
- RxCUI 2588062DailyMed set ID c0efa9f9-ca7a-471a-8030-99056fa5da09NDC 67877-882Application ANDA218502
Record updated 12 November 2026
Documents available
Documents that can be provided with this medicine. Your regulator may ask for more, and the quote lists the full set.
No document list is recorded for this medicine yet. Tell us which documents your regulator needs (for example a CoA, COPP or GMP certificate) when you request a quote.
Packs
| Pack | Code | Labeler | Marketed since |
|---|---|---|---|
| 1 bottle in 1 carton / 1 granule, for suspension in 1 bottle | 67877-882-71 | Ascend LaboratoriesIndia | 7 July 2025 |
Status by register
Where this medicine is registered, from the source record and the regulator data we hold. Ask us about a country that is not listed.
Import route
Pick the destination country to see the legal import route, who applies and typical timelines, from our import guide for that country.
Import guides are available for 25 countries. Pick one to see its route summary.
BrazilColombiaEgyptEthiopiaGhanaIraqKazakhstanKenyaAll import guides
Alternatives
Other makers and brands of Rivaroxaban 155 mg oral suspension.
Other strengths and forms of Rivaroxaban
Clinical summary
Rivaroxaban is a factor Xa inhibitor. It is available as tablets, oral suspension and kits. MedsAcross supplies Rivaroxaban for export from India to licensed hospitals, importers and physicians acting for named patients, with the documents each country requires.
Information from the US FDA prescribing information, retrieved 12 November 2026. Not yet medically reviewed.How we review
Read about RivaroxabanFor healthcare professionals and buyers. This is not medical advice. Treatment decisions belong to the prescriber.
Data sources
- DailyMed label record · Checked 12 November 2026
- Xarelto prescribing information (Janssen Pharmaceuticals) · U.S. National Library of Medicine, DailyMed
- Xarelto: European public assessment report (EPAR) · European Medicines Agency
- Rivaroxaban Accord: European public assessment report (EPAR) · European Medicines Agency
Need Rivaroxaban 155 mg oral suspension for your hospital or patient?
Send one request with the destination country and quantity. We confirm availability, lead time and the documents your regulator needs.